Jingxin Pharmaceutical: Ping An Securities Co., Ltd.\'s inspection opinion on the listing and circulation of Jingxin Pharmaceutical\'s non-public restricted shares
Zhejiang Jingxin Pharmaceutical: Investor relations management information of Zhejiang Jingxin Pharmaceutical as of August 16, 2024.
Zhejiang Jingxin Pharmaceutical: Special report on the collection and use of funds for the first half of 2024.
Zhejiang Jingxin Pharmaceutical: Announcement of the resolution of the Supervisory Board on the semi-annual report.
Zhejiang Jingxin Pharmaceutical: Announcement of Board of Directors' resolution for semi-annual report.
Zhejiang Jingxin Pharmaceutical: Ping An Securities Co., Ltd.'s verification opinion on Zhejiang Jingxin Pharmaceutical Co., Ltd.'s use of some idle funds raised to temporarily supplement working capital.
Zhejiang Jingxin Pharmaceutical: Announcement on the Temporary Supplement of Working Capital with Some Unused Raised Funds
Zhejiang Jingxin Pharmaceutical: Announcement regarding the return of raised funds.
Jingxin Pharmaceutical: 002020 Jingxin Pharmaceutical Investor Relations Management Information 20240408
Jingxin Pharmaceutical: 002020 Jingxin Pharmaceutical Investor Relations Management Information 20240402
Jingxin Pharmaceutical: Announcement on holding the 2023 Online Results Briefing
Jingxin Pharmaceutical: 2023 Annual Debriefing Report of the Company's Independent Directors (Zhang Daliang)
Jingxin Pharmaceutical: Annual Verification Report on the Use of Funds Raised
Jingxin Pharmaceutical: Internal Control Audit Report
Jingxin Pharmaceutical: 2023 Annual Audit Report
Jingxin Pharmaceutical: Remuneration and Assessment Committee Rules of Procedure (revised in March 2024)
Jingxin Pharmaceutical: 2023 Annual Debriefing Report of the Company\'s Independent Directors (Xu Pan)
Jingxin Pharmaceutical: Special Audit Report on the Profit Achievement Status of Guangdong Shaxi Pharmaceutical Co., Ltd. from 2021 to 2023
Jingxin Pharmaceutical: Special opinion of the board of directors on the evaluation of the independence of independent directors
Jingxin Pharmaceutical: Annual Special Audit Report on Related Party Capital Occupation
No Data
No Data